Core Viewpoint - The document outlines the regulations and procedures for the declaration, disclosure, and supervision of shareholding and trading activities by directors and senior management of Yingke Medical Technology Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2][3]. Group 1: Regulations on Shareholding and Trading - The regulations apply to all shares held by directors, senior management, and specified individuals or organizations, including shares in margin trading accounts [2]. - Directors and senior management must notify the board secretary in writing before trading company shares, ensuring compliance with laws against insider trading and market manipulation [2][3]. - There are specific prohibitions on transferring shares within one year of listing, within six months after leaving the company, and during investigations or legal proceedings related to securities violations [5][6]. Group 2: Trading Restrictions - Trading is prohibited during specific periods, such as 15 days before the announcement of annual or semi-annual reports and five days before quarterly reports [6][7]. - Directors and senior management must ensure that close relatives and controlled entities do not trade based on insider information [7]. - Personal stock accounts must be strictly managed, and financing transactions using company shares are not allowed [7][8]. Group 3: Reporting and Disclosure Requirements - Directors and senior management must report their trading plans to the board secretary and disclose shareholding changes within two trading days [11][12]. - Any reduction in shareholding must be reported to the Shenzhen Stock Exchange 15 trading days in advance, detailing the number of shares, time frame, and reasons for the reduction [11][12]. - If shareholding changes exceed certain thresholds, additional reporting obligations under the relevant acquisition regulations apply [12][13]. Group 4: Violations and Responsibilities - Violations of trading regulations may result in penalties, including the recovery of profits from illegal trades and potential civil liabilities for significant losses caused to the company [23][24]. - The company may impose disciplinary actions based on the severity of the violation, including warnings, demotions, or legal actions for serious breaches [24][25]. - The document emphasizes adherence to laws and regulations, with the board of directors holding the authority for interpretation and amendments [25][26].
英科医疗: 董事及高级管理人员所持公司股份的变动管理制度